Louis L. Pisters

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-9226-6062

发表论文 521 篇 · 总被引 18712 次 · h-index 71

代表论文

Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series (2024 · Clinical Cancer Research · 被引 33)
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance (2024 · Biomarker Research · 被引 7)
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life (2024 · JAMA Network Open · 被引 6)
A phase II trial of apalutamide for intermediate‐risk prostate cancer and molecular correlates (2024 · British Journal of Urology · 被引 4)
Grade Group 1 Core Volume at Time of Biopsy Is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy (2025 · JU Open Plus · 被引 3)
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer (2026 · European Urology · 被引 2)